Grand Cayman, Cayman Islands, April 23, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA ...
VANCOUVER, BC / ACCESS Newswire / September 19, 2025 / Onco-Innovations Limited (ONCO:CA) (CBOE CA:ONCO )(OTCQB:ONNVF )(Frankfurt:W1H) (WKN: A3EKSZ ) (" Onco " or the ...
Design of experiment plays a crucial role in the optimization process of formulation development. The process, equipment, and technology for developing and manufacturing oral solid-dosage forms are ...
Lack of toxicity data and poor physicochemical properties must be overcome. More than 25% of drugs on the market worldwide and candidates in the pharmaceutical pipeline were considered to be ...
VANCOUVER, BC / ACCESS Newswire / September 19, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H) (WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that Dalton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback